• Drug information
• Practical tips
• Management & treatment
• Specific populations
• Professional development
  • AOD training (resource kit)
  • AOD handbook
• Resources

   

Alcohol & other drugs handbook

• Front Cover of the Handbook (PDF 97 KB)
• Coverpage, Copyright Notice and Suggested Citation (PDF 35 KB)
• About This Handbook, Acknowledgments, List of Contributors; Contents – Overview, Contents – Detailed, List of tables (PDF 69KB)

Part 1: Overview and Introduction

1. Overview and Introduction (PDF 135 KB)
2. General Principles of Management and Intervention (PDF 102 KB)

Part 2: The Drugs

3. Alcohol (PDF 259 KB)
4. Tobacco (PDF 143 KB)
5. Cannabis (PDF 59 KB)
6. Amphetamines (PDF 154 KB)
7. Ecstasy (PDF 91 KB)
8. Cocaine (PDF 116 KB)
9. Heroin and Other Opioids (PDF 157 KB)
10. Volatile Substances (PDF 112 KB)
11. Benzodiazepines (PDF 104 KB)
12. Other Drugs (PDF 91 KB)

Part 3: Non-medical Interventions

13. Psychosocial Interventions (PDF 144 KB)
14. Alternative Therapies (PDF 50 KB)

Part 4: Issues for Special Consideration

15. Pregnancy and Drug Use (PDF 84 KB)
16. Surgery and Substance Use (PDF 64 KB)
17. Managing Chronic Pain (PDF 105 KB)
18. Coexisting Mental Illness (PDF 118 KB)
19. Injecting and Communicable Diseases (PDF 85 KB)
20. Drug Issues in Correctional Services (PDF 86 KB)
21. Health Professionals As Patients (PDF 58 KB)
22. Gambling (PDF 85 KB)

Part 5: Appendices and Glossary

1. NHMRC Alcohol Guidelines – Short- and Long-term Risk (PDF 49 KB)
2. Laboratory Markers for Alcohol-related Damage (PDF 47 KB)
3. AUDIT – Interview Version (PDF 49 KB)
4. AUDIT – Self-report Version (PDF 47 KB)
5. Alcohol Withdrawal Assessment Scale (CIWA–AR) (PDF 40 KB)
6. Tip Sheet for Reducing Alcohol Consumption (PDF 38 KB)
7. Alcohol Withdrawal Observation Chart (PDF 57 KB)
8. The Five ‘A’s (PDF 37 KB)
9. Hepatitis C Referral Checklist (PDF 23 KB)
10. Proforma for Decision Balance Worksheet (PDF 22 KB)
11. CREATE (PDF 41 KB)
    Glossary (PDF 189 KB)

List of Tables

• Table 1-1. Intoxication and potential adverse health effects (PDF 58 KB)
• Table 1–2. Criteria for substance dependence (PDF 38 KB)
• Table 1–3. Why health care workers are influential amongst Indigenous people (PDF 35 KB)
• Table 2–1 Treatment success for dependence (PDF 49 KB)
• Table 3–1 Correlation between BAC* and behavioural / motor impairment (PDF 71 KB)
• Table 3–2 Standard drink (SD) equivalents (PDF 47 KB)
• Table 3–3 Classification of alcohol-related harms (PDF 84 KB)
• Table 3–4 Using the AUDIT score with the FLAGS approach for treatment interventions (PDF 99 KB)
• Table 3–5 Medications commonly used for withdrawal management (PDF 55 KB)
• Table 3–6 Diazepam regime for home / outpatient withdrawal (PDF 59 KB)
• Table 3–7 Pharmacotherapies indicated for alcohol dependence therapies (PDF 56 KB)
• Table 4–1 Benefits of quitting smoking (PDF 66 KB)
• Table 4–2 Pharmacotherapy of nicotine replacement therapies (PDF 58 KB)
• Table 4–3 Pharmacotherapy of bupropion (PDF 58 KB)
• Table 6–1 Routes of administration, effects and risks (PDF 56 KB)
• Table 6–2 Potential acute physical effects from using low and high doses of amphetamines (PDF 65 KB)
• Table 6–3 Amphetamine-related harms (PDF 40 KB)
• Table 7–1 Physical effects of ecstasy (PDF 54 KB)
• Table 9–1 Opioid effects (PDF 65 KB)
• Table 9–2 Methadone effects and duration (PDF 58 KB)
• Table 9–3 Common symptoms and time frames of opioid withdrawal (PDF 69 KB)
• Table 9–4 Factors impacting upon severity of withdrawal (PDF 45 KB)
• Table 9–5 Symptomatic medications for opioid withdrawal (PDF 67 KB)
• Table 10–1 Major volatile substances and their sources (PDF 63 KB)
• Table 11–1 Drug interactions (PDF 44 KB)
• Table 11–2 Benzodiazepine equivalence table (PDF 37 KB)
• Table 12–1 Management of GHB intoxication (PDF 38 KB)
• Table 13–1 Patient-centred approach (PDF 61 KB)
• Table 18–1 Mental health problems commonly associated with psychoactive drug use (PDF 38 KB)
• Table 20–1 Needle Syringe Program male and female clients who were imprisoned and injected in prison in 1996 (PDF 35 KB)
• Table 20–2 Implementation of prevention measures in Australian prisons (2002 ) (PDF 45 KB)
• Table 21–1 Doctors’ Health Advisory Services (PDF 38 KB)
• Table A–1 Risk of harm in the short term (PDF 48 KB)
• Table A–2 Risk of harm in the long term (PDF 48 KB)

Large File Warning
* If your browser opens Adobe Acrobat files within the browser window, it is strongly recommended that the following procedure be used to access all these files: Click the link with the RIGHT mouse button, Choose "Save Target As..." (Internet Explorer) OR "Save Link As..." (Netscape), Select an appropriate folder on a local drive to place the downloaded file. Attempting to open large Adobe Acrobat files within the browser window may lead to system problems. You will need to have the Adobe Acrobat reader installed on your computer to view PDF files.

To view PDF (Portable Document Format) documents, you will need to have a PDF reader installed on your computer. The Adobe Acrobat Reader is available free of charge from Adobe's website.